Amixicile: A Concept Therapeutic for Treatment of Chronic Anaerobic Infections

Source: British Journal of Gastroenterology (2019)

Amixicile is a selective anaerobic microbial therapeutic in development to treat chronic infections caused by anaerobic bacteria including periodontal disease and is designed for use for long term management of colitis caused by Clostrioides difficile.

Amixicile-_A_Concept_Therapeutic_for_Treatment_of_Chronic_Anaerobic_Infections

.pdf

Download PDF • 422KB